ANI Pharmaceuticals Inc. held its 2025 Annual Meeting of Stockholders on May 22, 2025. During the meeting, stockholders approved the Amended and Restated 2022 Stock Incentive Plan and the Amended and Restated 2016 Employee Stock Purchase Plan. The appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. An amendment to the Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 33,333,334 to 66,000,000 shares was also approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.